Argos Q2 results

Argos Therapeutics (ARGS +2.5%) Q2 results: Revenues: $0.5M (-62.5%); Net Loss: ($12.0M) (-107.0%); Loss Per Share: ($0.61) (+97.6%); Quick Assets: $71.8M (+52.8%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs